Investor's Business Daily on MSN5 分钟
Axsome Flashes A Bearish Signal On Mixed Results In Alzheimer's Agitation
Shares of Axsome Therapeutics dropped Monday on mixed test results for its Alzheimer's disease agitation treatment.